Medical Oncologist
CION Cancer Clinics
Who is offered risk-reducing surgery? | CION Cancer Clinics
Preventive cancer surgery is offered to people whose chance of a particular cancer is far above the ordinary and can be measured: usually a confirmed inherited gene fault such as BRCA1, BRCA2, Lynch syndrome, CDH1, FAP or MEN2, or a family pattern strong enough for a genetics team to class them as high risk. This page explains who reaches that offer, who usually does not, and how it is made. It will not tell you what to choose. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
MI
Medically reviewed by Dr. Mohammed ImaduddinConsultant Surgical Oncologist · MBBS, MS (General Surgery), MCh (Surgical Oncology) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Who is actually offered preventive cancer surgery?
- Which inherited conditions lead to the offer?
- Words you will see on a genetics letter, in plain language
- Who is usually not offered it?
- How does the offer actually reach you?
- Four things families tell us, and what is actually true
- Common questions about who is offered preventive surgery
The short answer
Who is actually offered preventive cancer surgery?
Preventive surgery is offered to people whose chance of a particular cancer is far above the ordinary, and who can be shown to be in that group. In practice that means a confirmed inherited gene fault, or a family pattern so strong that a genetics team treats it as high risk even without one.
Why the bar is set so high
Removing a healthy organ carries real harm: an operation, a recovery, and permanent changes to the body. That harm is only worth taking on when the risk being removed is large. For someone at ordinary risk, the operation would cause more trouble than it prevents. So the offer is made only after the risk has been measured, not guessed.
Offered, not prescribed
Being in the group does not mean you must have surgery. It means the option is put on the table beside the others: regular checks, and in some cases risk-lowering medicines. Many people in the group choose checks for years, and that is a recognised path. What follows describes who reaches the table. It does not say what any one person should do.
If you are reading this because a relative has just been told they carry a gene fault, the first step for you is a genetics referral, not a surgical one.The groups
Which inherited conditions lead to the offer?
Each condition is linked to particular organs. Being a carrier does not put every organ at risk, and the offer is made organ by organ.
BRCA1 and BRCA2
The commonest reason. Carriers have a high lifetime chance of breast cancer and of ovarian cancer. Removal of the ovaries and tubes, and removal of both breasts, are each discussed separately.
Lynch syndrome
Raises the chance of bowel cancer and, in women, of womb and ovarian cancer. Colonoscopy checks do most of the work; removing the womb and ovaries may be discussed after childbearing.
CDH1
Linked to a stomach cancer that grows in a scattered way scopes cannot see early, so removing the whole stomach is discussed. Women with CDH1 also carry a raised breast cancer risk.
FAP
Familial adenomatous polyposis produces hundreds of bowel polyps, some of which will turn into cancer. Removing most or all of the colon is offered, often in the late teens or twenties.
MEN2
A RET gene fault that leads to thyroid cancer, sometimes in early childhood. Removal of the thyroid is offered young, with the age guided by the exact change found.
Strong family history without a known fault
Some families have several early cancers but no fault can be found. A genetics team can still class a person as high risk from the family tree alone.
Not sure whether this applies to you?
Ask an oncologistOn your letter
Words you will see on a genetics letter, in plain language
- Pathogenic variant
- A change in a gene that is known to raise cancer risk. This is what "positive" means on a report. It is not a diagnosis of cancer.
- Variant of uncertain significance (VUS)
- A change whose meaning is not yet known. It does not put you in the high-risk group, and surgery is not offered on the strength of it.
- Lifetime risk
- The chance of developing a cancer at some point in your life. A carrier's figure is much higher than the general figure, but it is still a chance, not a certainty.
- Penetrance
- How often a gene fault actually leads to cancer. Some faults lead to cancer in most carriers; others in fewer.
- Surveillance
- Regular checks, such as MRI scans or colonoscopy, timed to catch a cancer early. The alternative to surgery for most carriers.
- Multidisciplinary team (MDT)
- The specialists who discuss your case together before the options are put to you, usually including a geneticist and a surgical oncologist.
Being straight with you
Who is usually not offered it?
Most people who worry about cancer are not in the group, and a surgeon will say so. One relative with cancer, a cancer in the family at an older age, or a general fear of the disease do not on their own raise risk enough for surgery to be sensible.
A VUS or a negative test
A result of "uncertain significance" is not a positive result. A negative test in a family where the fault is known means you did not inherit it, and your risk is close to the general population. In both cases surgery is not offered, though the genetics team may still suggest checks based on the family tree.
Timing and health
Some carriers are in the group but not ready. A woman who plans to have children is usually advised that ovary removal can wait until that is complete. A person who is unwell with another condition may be steered towards checks until they are fitter. A young carrier of a breast cancer gene is often offered scans first, because the risk rises with age and the operation can be timed later.
People who do not want it
Being a carrier does not oblige you to have surgery. Choosing checks instead is a recognised decision, and you can revisit it at any later appointment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
The pathway
How does the offer actually reach you?
A referral to genetics
Usually from a treating oncologist, a family doctor or a relative's team. You can also ask for one yourself if the family pattern worries you.
Counselling and the test
The family tree is drawn, the test is explained, and you decide whether to have it. Where possible, a relative who had cancer is tested first so the family knows which fault to look for.
The tumour board
A positive result is discussed by geneticists, surgical oncologists and other specialists together. They agree which organs are at risk and which options apply to you.
The options meeting
You are told the choices: checks, medicines where they exist, and surgery. Bring the family member who will help you decide. Nothing is booked at this meeting unless you want it to be.
Commonly believed
Four things families tell us, and what is actually true
"Cancer runs in our family, so we all need the operation."
A family history is the reason to be assessed, not a reason to operate. Within one family some members will carry the fault and some will not. Only those who carry it, or who are classed high risk from the tree, reach the surgical discussion.
"I am a man, so BRCA does not matter to me."
Men carry and pass on BRCA faults just as women do, and male carriers have a raised chance of prostate and some other cancers. Preventive surgery is rarely offered to men, but testing and checks are, and their daughters and sons may want to know.
"If I test positive, I will be pushed into surgery."
A positive result opens a conversation, not a booking. Checks are a recognised alternative for most gene faults, and the timing of any surgery is yours to set with the team.
"My test was negative, so my children are safe."
If the family fault is known and you do not carry it, you cannot pass it on, and that is real reassurance. If no fault was ever found in the family, a negative test means less, and the genetics team will explain what it does and does not cover.
Questions we are asked
Common questions about who is offered preventive surgery
My mother and aunt both had breast cancer. Am I in the group?
You may be, and that pattern is a clear reason to ask for a genetics referral. Two close relatives, particularly if either was young at diagnosis, is the kind of history a genetics team looks at closely. Whether surgery is discussed depends on what the assessment and any test show.
Can I ask for preventive surgery without a gene test?
You can ask, but a surgeon will want a risk assessment first. Without a test or a very strong family tree, the risk being removed is small and the harms of the operation are not. A genetics team can sometimes class a person as high risk from the family history alone.
Is there an age below which it is not offered?
For most adult conditions, surgery is timed to when the risk starts to climb, so a young carrier is usually offered checks first. The exceptions are FAP and MEN2, where the cancer can start in childhood or the teens and surgery is offered young. Your team will tell you the usual timing for your gene.
Does having a gene fault mean I will definitely get cancer?
No. It means your chance is much higher than usual, and for some faults very high, but it is still a chance. Some carriers never develop the cancer. That is why the options are laid out as choices, and why checks are a recognised path for many.
I already had cancer in one breast. Is removing the other preventive surgery?
Yes, in effect. Removing the unaffected breast is a risk-reducing operation, discussed most often in women who carry a BRCA fault or have a very strong family history. For women without those, the team will explain that the benefit is smaller than many expect.
Who decides: the geneticist or the surgeon?
Neither alone. The geneticist measures the risk and the surgeon explains the operation, and the case is discussed at a tumour board before the options reach you. The decision itself is yours. Ask your centre whether both specialists are involved.
Will Aarogyasri or my insurer cover surgery on a healthy organ?
Cover varies and should be settled before anything is booked. Some schemes and insurers cover risk-reducing surgery when a gene fault is documented; others treat it differently from cancer treatment. Bring your Aarogyasri, CGHS, ECHS or EHS card, or your policy, to the first consultation and the helpline will check your specific cover.
Is the offer different in India from abroad?
The medical grounds are the same, because they rest on the same gene faults and the same evidence. What differs is access to genetic counselling and testing, and how families talk about it. In Hyderabad both are available. Ask your centre how it links genetics, surgery and follow-up.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ)
- National Cancer Institute — Genetics of Colorectal Cancer (PDQ)
- NHS — Predictive genetic tests for cancer risk genes
- NICE — Familial breast cancer: classification, care and managing breast cancer and related risks (CG164)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Risk-Reducing Surgery: Operating Before Cancer HappensWhat the operation is and which organs it coversGenetic Testing Before Preventive SurgeryThe test that decides whether you are in the groupSurveillance Instead of Preventive SurgeryThe recognised alternative for most carriersTalking to Your Family About Genetic RiskA result in one person is a result for the familyChoosing a Surgeon and a CentreWhat to ask about genetics, tumour boards and follow-up
Talk to us
Not sure whether your family history counts?
Tell us what has been found so far and we will help you reach a genetics assessment or a surgical oncologist, whichever is the right next step. One helpline serves every CION centre.